Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002407 · ClinicalTrials.gov registry record · NA
A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
NCT00002407: Completed NA study, sponsored by Weill Medical College of Cornell University.
NCT00002407 is a NA study that has completed, run by Weill Medical College of Cornell University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002407, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to see if it is safe and effective to give one of three different triple-drug combinations to HIV-infected patients who have never been treated with anti-HIV drugs.
Interventions
- DRUG Lamivudine
- DRUG Indinavir sulfate
- DRUG Stavudine
- DRUG Didanosine
- DRUG Nevirapine
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002407 record still lists
NCT00002407 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which Lamivudine is the first listed.
NCT00002407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002407 about?
NCT00002407 is a clinical study titled "A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs". The purpose of this study is to see if it is safe and effective to give one of three different triple-drug combinations to HIV-infected patients who have never been treated with anti-HIV drugs.
What is the current status of trial NCT00002407?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002407?
The interventions under investigation include: Lamivudine (DRUG), Indinavir sulfate (DRUG), Stavudine (DRUG), Didanosine (DRUG), Nevirapine (DRUG).
Who is sponsoring clinical trial NCT00002407?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.